Balance Sheet
AssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Other Non-Current Assets (2019 - 2025)

Benitec Biopharma's Other Non-Current Assets history spans 6 years, with the latest figure at $55000.0 for Q1 2025.

  • For Q1 2025, Other Non-Current Assets changed N/A year-over-year to $55000.0; the TTM value through Mar 2025 reached $55000.0, changed N/A, while the annual FY2024 figure was $25000.0, 74.23% down from the prior year.
  • Other Non-Current Assets for Q1 2025 was $55000.0 at Benitec Biopharma, up from $25000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $156000.0 in Q1 2022 and bottomed at $9000.0 in Q2 2021.
  • The 5-year median for Other Non-Current Assets is $25000.0 (2021), against an average of $60181.8.
  • The largest annual shift saw Other Non-Current Assets soared 1400.0% in 2022 before it plummeted 74.23% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $25000.0 in 2021, then changed by 0.0% to $25000.0 in 2022, then soared by 240.0% to $85000.0 in 2023, then plummeted by 70.59% to $25000.0 in 2024, then soared by 120.0% to $55000.0 in 2025.
  • Per Business Quant, the three most recent readings for BNTC's Other Non-Current Assets are $55000.0 (Q1 2025), $25000.0 (Q4 2024), and $25000.0 (Q2 2024).